Heart scan strategy aims to slash cardiac events in rural china

NCT ID NCT07416344

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study tests whether using a special heart CT scan to guide intensive treatment can reduce major heart problems like heart attacks and strokes compared to standard care. About 15,000 high-risk adults aged 40-75 in rural China will take part. The goal is to see if this personalized approach leads to fewer deaths and heart-related emergencies over 18 months, with a longer follow-up at 36 months.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Beidahuang Industry Group General Hospital

    Harbin, Heilongjiang, 150088, China

  • Beijing Peking University WBL Biotech Co., Ltd

    Beijing, Municipality of Beijing, 100080, China

  • DaQing Oilfield Hospital

    Daqing, Heilongjiang, 163001, China

  • Daqing Longnan Hospital

    Daqing, Heilongjiang, 163453, China

  • Hegang People Hospital

    Hegang, Heilongjiang, 154100, China

  • Heilongjiang Provincial Hospital, China

    Harbin, Heilongjiang, 150036, China

  • Hongqi Hospital Affiliated to Mudanjiang Medical University

    Mudanjiang, Heilongjiang, 157011, China

  • Jiamusi Central Hospital

    Jiamusi, Heilongjiang, 154002, China

  • Mudanjiang Cardiovascular Hospital, China

    Mudanjiang, Heilongjiang, 157011, China

  • Shuangyashan Shuangkuang Hospital

    Shuangyashan, Heilongjiang, 155100, China

  • The Baoquanling Hospital of Beidahuang Group

    Hegang, Heilongjiang, 154211, China

  • The First Affiliated Hospital of Jiamusi University, China

    Jiamusi, Heilongjiang, 154003, China

  • The First Hospital of Qiqihar

    Qiqihar, Heilongjiang, 161005, China

  • The First Hospital of Suihua City

    Suihua, Heilongjiang, 152000, China

  • The Second Affiliated Hospital of Harbin Medical University

    Harbin, Heilongjiang, 150086, China

  • The Third Affiliated Hospital of Qiqihar Medical University

    Qiqihar, Heilongjiang, 161000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.